In-vitro comparison of tobramycin nebulised using two different nebuliser systems Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin Source: Eur Respir J, 55 (5) 1901903; 10.1183/13993003.01903-2019 Year: 2020
An initial investigation by electronic survey of current UK physiotherapy practice into the use and delivery of nebulised isotonic saline Source: Annual Congress 2012 - New insights in the physical assessment and therapy of respiratory patients Year: 2012
Delivery of a suspension corticosteroid formulation by small volume nebulizers: a comparative bench study Source: Eur Respir J 2001; 18: Suppl. 33, 134s Year: 2001
Stability of a new formulation of intravenous epoprostenol sodium Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
In-vitro deposition study of a levofloxacin (LEV) solution into a novel human nasal cast model by the PARI VibrENTÔSource: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis Source: Eur Respir Rev 2013; 22: 476-486 Year: 2013
Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Bioequivalence of a new formulation of omalizumab, solution for injection in prefilled syringe, to the current lyophilized formulation Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Clinical efficacy of bolus versus continuous-infusion of piperacillin-tazobactam in VAP treatment Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Clinical efficacy of new non-freon aerosol troventol in asthma patients Source: Annual Congress 2006 - Recent advances in asthma treatment Year: 2006
The effect of nebulizer systems in inhaled tobramycin Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010
A randomized controlled study of the efficacy and safety of nebulized lidocaine vs instilled lidocained as an anesthetic prior to flexible bronchoscopy Source: Eur Respir J 2006; 28: Suppl. 50, 596s Year: 2006
Use of an electronic monitoring system to generate objective information on patients’ adherence to taking treatments of a novel inhaled tobramycin solution Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005
Therapeutic and diagnostic use of highly concentrated sodium chloride solution inhalations in pulmonology Source: Eur Respir J 2006; 28: Suppl. 50, 62s Year: 2006
Clinical efficacy of arbekacin on MRSA pneumonia by intramuscularly injection Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Delivery efficiency of electronic and jet nebulisers aerosolising a colistimethate sodium solution Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009
Evaluation of moxifloxacin (MXF) as empiric antibiotic therapy of CAP outpatients: A multicenter prospective study Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design Source: ERJ Open Res, 5 (4) 00061-2019; 10.1183/23120541.00061-2019 Year: 2019